Anticoagulation in patients with inferior vena cava agenesia
- 13 June 2024
- journal article
- editorial
- Published by Elsevier in The Lancet Haematology
- Vol. 11 (8) , e555-e556
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational studyThe Lancet Haematology, 2024
- Agenesis of the Intrahepatic Inferior Vena Cava: A Case Report and Literature ReviewCureus, 2023
- Safety, efficacy and prognosis of anticoagulant therapy for portal vein thrombosis in cirrhosis: a retrospective cohort studyThrombosis Journal, 2023
- Prevalence of Inferior Vena Cava Anomalies and Their Significance and Impact in Clinical PracticeEuropean Journal of Vascular and Endovascular Surgery, 2022
- Maternal inherited thrombophilia and pregnancy outcomesExperimental and Therapeutic Medicine, 2020
- Review of Budd-Chiari SyndromeJournal of Interventional Medicine, 2020
- Pelvic congestion syndrome due to agenesis of the infrarenal inferior vena cavaRadiology Case Reports, 2018
- Aspirin for the Prevention of Recurrent Venous ThromboembolismCirculation, 2014
- Apixaban for Extended Treatment of Venous ThromboembolismNew England Journal of Medicine, 2013
- Chronic venous insufficiency in patients with absence of the inferior vena cavaJournal of Vascular Surgery: Venous and Lymphatic Disorders, 2013